The Claim
Apigenin reduces the expression of IL-6, IL-8, and ICAM-1 at both mRNA and protein levels in human umbilical vein endothelial cells exposed to di-(2-ethylhexyl) phthalate (DEHP).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin lowers the levels of IL-6, IL-8, and ICAM-1 molecules in human blood vessel cells exposed to DEHP, a common environmental chemical.
See the scientific wording
Apigenin significantly reduces the expression of IL-6, IL-8, and ICAM-1 at both mRNA and protein levels in human umbilical vein endothelial cells exposed to di-(2-ethylhexyl) phthalate (DEHP), suggesting a potential anti-inflammatory effect in vascular endothelial cells under environmental toxin stress.
When a toxic chemical enters blood vessel cells, it turns on a signaling pathway called JNK that makes the cells produce inflammatory signals. A natural compound called apigenin stops this JNK pathway from turning on. Without JNK activity, the cells stop making the inflammatory signals IL-6, IL-8, and ICAM-1, and fewer immune cells stick to the blood vessel walls.
What the research says
1 studyApigenin, a natural plant compound, was shown to calm down harmful inflammation signals in human blood vessel cells when those cells were exposed to a common chemical pollutant (DEHP). This suggests apigenin might help protect blood vessels from damage caused by environmental toxins.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.